Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like Gilead Could Acquire Galapagos Within Weeks December 17, 2017 Pliant Appoints Ph.D., As Vice President Of Chemistry And M.D., Ph.D. To The Board Of Directors September 25, 2017 Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress September 28, 2017
Pliant Appoints Ph.D., As Vice President Of Chemistry And M.D., Ph.D. To The Board Of Directors September 25, 2017
Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress September 28, 2017
